|
SRD5A1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.074000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.431200E-01 |
| Normal-vs-Stage2 |
4.010300E-02 |
| Normal-vs-Stage3 |
1.939550E-01 |
| Normal-vs-Stage4 |
5.883500E-02 |
| Stage1-vs-Stage2 |
1.087980E-01 |
| Stage1-vs-Stage3 |
3.944000E-01 |
| Stage1-vs-Stage4 |
1.380570E-01 |
| Stage2-vs-Stage3 |
5.649000E-01 |
| Stage2-vs-Stage4 |
8.105000E-01 |
| Stage3-vs-Stage4 |
7.207200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.767990E-02 |
| Normal-vs-AfricanAmerican |
9.241900E-02 |
| Normal-vs-Asian |
3.704800E-01 |
| Caucasian-vs-AfricanAmerican |
1.101770E-03 |
| Caucasian-vs-Asian |
3.693000E-01 |
| AfricanAmerican-vs-Asian |
9.131000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.717500E-03 |
| Normal-vs-Female |
5.997600E-01 |
| Male-vs-Female |
1.441470E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.304800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.335200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.278400E-02 |
| Normal-vs-Age(81-100Yrs) |
2.272400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.543700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.529600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.493600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.194000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.311400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.251200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.044900E-03 |
| Normal-vs-Grade 2 |
4.528800E-01 |
| Normal-vs-Grade 3 |
1.153760E-02 |
| Normal-vs-Grade 4 |
3.164800E-01 |
| Grade 1-vs-Grade 2 |
4.320000E-03 |
| Grade 1-vs-Grade 3 |
2.611400E-04 |
| Grade 1-vs-Grade 4 |
8.317500E-03 |
| Grade 2-vs-Grade 3 |
6.881600E-02 |
| Grade 2-vs-Grade 4 |
5.224200E-01 |
| Grade 3-vs-Grade 4 |
7.338000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.548300E-02 |
| Normal-vs-ccB subtype |
3.177800E-01 |
| ccA subtype-vs-ccB subtype |
5.540400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.871700E-02 |
| Normal-vs-N1 |
1.655800E-01 |
| N0-vs-N1 |
2.464000E-01 |
|
|
